Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines against Neisseria meningitidis groups Y and W135

This publication has 18 references indexed in Scilit:

• Development of vaccines against meningococcal disease
  The Lancet, 2002
• Synthetic Polysaccharide Type 3-Related Di-, Tri-, and Tetrasaccharide–CRM ₁₉₇ Conjugates Induce Protection against Streptococcus pneumoniae Type 3 in Mice
  Infection and Immunity, 2001
• Meningococcal polysaccharide-protein conjugate vaccines
  International Journal of Infectious Diseases, 1997
• Full 1H NMR assignment and detailed O-acetylation patterns of capsular polysaccharides from Neisseria meningitidis used in vaccine production
  Carbohydrate Research, 1996
• α2-8 Sialic Acid Polymers: Size, Structure, and Compositional Analysis
  Analytical Biochemistry, 1994
• Carbohydrate composition analysis of bacterial polysaccharides: Optimized acid hydrolysis conditions for HPAEC-PAD analysis
  Analytical Biochemistry, 1992
• Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates.
  Journal of Clinical Investigation, 1992
• A quantitative determination by capillary gas-liquid chromatography of neutral and amino sugars (as O-methyloxime acetates), and a study on hydrolytic conditions for glycoproteins and polysaccharides in order to increase sugar recoveries
  Analytical Biochemistry, 1984
• Structural determination of the polysaccharide antigens of Neisseria meningitidis serogroups Y, W-135, and BO
  Canadian Journal of Biochemistry, 1976
• Quantitive estimation of sialic acids
  Biochimica et Biophysica Acta, 1957